Biote Corp

BTMD

Company Profile

  • Business description

    Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

  • Contact

    1875 W. Walnut Hill Lane
    Suite 100
    IrvingTX75038
    USA

    T: +1 844 604-1246

    https://www.biote.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Care Facilities

    Fiscal Year End

    31 December 2026

    Employees

    223

Stocks News & Analysis

stocks

Tesla: Reported China divestiture plan could clear path for SpaceX merger

Media report says Tesla is exploring divestiture plans to ease regulatory approval of a Tesla-SpaceX merger.
stocks

This onetime AI market darling is now surprisingly undervalued

This AI leader qualifies as a GARP stock today.
stocks

Undervalued ASX miner hits production homerun

Record volumes, lower costs and reduced debt underpin a stronger earnings outlook for ASX miner.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,137.0070.20-0.76%
CAC 408,509.6424.000.28%
DAX 4025,629.2417.210.07%
Dow JONES (US)52,485.03276.970.53%
FTSE 10010,868.0529.22-0.27%
HKSE25,884.4325.550.10%
NASDAQ25,373.85251.681.00%
Nikkei 22564,362.022,494.594.03%
NZX 50 Index13,699.2863.50-0.46%
S&P 5007,489.7252.090.70%
S&P/ASX 2008,976.8073.10-0.81%
SSE Composite Index3,832.2627.570.72%

Market Movers